Works matching IS 01615505 AND DT 2023 AND VI 64 AND IP 11

Results: 30

HER2-Low Breast Cancer Can Be Visualized by HER2 PET.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1841, doi. 10.2967/jnumed.123.266101

By:

Altena, Renske;
af Burén, Siri;
Thuy Tran;
Axelsson, Rimma

Publication type:

Article

REPLY.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1841, doi. 10.2967/jnumed.123.266490

By:

Seban, Romain-David

Publication type:

Article

Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [68Ga]Ga-FAPI-46 PET-Positive and [18F]FDG PET-Negative.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1839, doi. 10.2967/jnumed.123.265498

By:

Maliha, Peter George;
Mendelsohn, Abie H.;
Czernin, Johannes;
Howard, Taylor;
Calais, Jeremie;
Hotta, Masatoshi

Publication type:

Article

Total-Body Perfusion Imaging with [11C]-Butanol.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1831, doi. 10.2967/jnumed.123.265659

By:

Li, Elizabeth J.;
López, Javier E.;
Spencer, Benjamin A.;
Abdelhafez, Yasser;
Badawi, Ramsey D.;
Guobao Wang;
Cherry, Simon R.

Publication type:

Article

Total-Body Multiparametric PET Quantification of 18F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1821, doi. 10.2967/jnumed.123.265723

By:

Yiran Wang;
Nardo, Lorenzo;
Spencer, Benjamin A.;
Abdelhafez, Yasser G.;
Li, Elizabeth J.;
Omidvari, Negar;
Chaudhari, Abhijit J.;
Badawi, Ramsey D.;
Jones, Terry;
Cherry, Simon R.;
Guobao Wang

Publication type:

Article

Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for 89Zr-Trastuzumab.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1815, doi. 10.2967/jnumed.123.265621

By:

Mohr, Philipp;
van Sluis, Joyce;
Providência1, Laura;
van Snick, Johannes H.;
Lub-de Hooge, Marjolijn N.;
Willemsen, Antoon T.;
Glaudemans, Andor W. J. M.;
Boellaard, Ronald;
Lammertsma, Adriaan A.;
Brouwers, Adrienne H.;
Tsoumpas, Charalampos

Publication type:

Article

Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1806, doi. 10.2967/jnumed.123.265649

By:

Rezazadeh, Farzaneh;
Ramos, Nicholas;
Saliganan, Allen-Dexter;
Al-Hallak, Najeeb;
Kang Chen;
Mohamad, Bashar;
Wiesend, Wendy N.;
Viola, Nerissa T.

Publication type:

Article

Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1798, doi. 10.2967/jnumed.123.265941

By:

Gogola, Alexandra;
Lopresti, Brian J.;
Tudorascu, Dana;
Snitz, Beth;
Minhas, Davneet;
Doré, Vincent;
Ikonomovic, Milos D.;
Shaaban, C. Elizabeth;
Matan, Cristy;
Bourgeat, Pierrick;
Mason, N. Scott;
Aizenstein, Howard;
Mathis, Chester A.;
Klunk, William E.;
Rowe, Christopher C.;
Lopez, Oscar L.;
Cohen, Ann D.;
Villemagne, Victor L.

Publication type:

Article

Optimized Methods for the Production of High-Purity 203Pb Using Electroplated Thallium Targets.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1791, doi. 10.2967/jnumed.123.265976

By:

Saini, Shefali;
Bartels, Jennifer L.;
Appiah, Jean-Pierre K.;
Rider, Jason H.;
Baumhover, Nicholas;
Schultz, Michael K.;
Lapi, Suzanne E.

Publication type:

Article

Second Symposium of the European Working Group on the Radiobiology of Molecular Radionuclide Therapy.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1788, doi. 10.2967/jnumed.123.265956

By:

Nonnekens, Julie;
Cornelissen, Bart;
Terry, Samantha Y. A.

Publication type:

Article

Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1779, doi. 10.2967/jnumed.123.265763

By:

Grkovski, Milan;
O'Donoghue, Joseph A.;
Imber, Brandon S.;
Andl, George;
Cheng Tu;
Lafontaine, Daniel;
Schwartz, Jazmin;
Thor, Maria;
Zelefsky, Michael J.;
Humm, John L.;
Bodei, Lisa

Publication type:

Article

Tandem Isotope Therapy with 225Ac- and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1772, doi. 10.2967/jnumed.123.265433

By:

Meyer, Catherine;
Stuparu, Andreea;
Lueckerath, Katharina;
Calais, Jeremie;
Czernin, Johannes;
Slavik, Roger;
Dahlbom, Magnus

Publication type:

Article

Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1765, doi. 10.2967/jnumed.123.265878

By:

Karimzadeh, Amir;
Soeiro, Paula;
Feuerecker, Benedikt;
Hecker, Charlotte-Sophie;
Knorr, Karina;
Heck, Matthias M.;
Tauber, Robert;
D'Alessandria, Calogero;
Weber, Wolfgang A.;
Eiber, Matthias;
Rauscher, Isabel

Publication type:

Article

Prediction of Response to 177Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1758, doi. 10.2967/jnumed.122.264953

By:

Hohberg, Melanie;
Reifegerst, Manuel;
Drzezga, Alexander;
Wild, Markus;
Schmidt, Matthias

Publication type:

Article

A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1750, doi. 10.2967/jnumed.122.265001

By:

Jingliang Zhang;
Fei Kang;
Jie Gao;
Jianhua Jiao;
Zhiyong Quan;
Shuaijun Ma;
Yu Li;
Shikuan Guo;
Zeyu Li;
Yuming Jing;
Keying Zhang;
Fa Yang;
Donghui Han;
Weihong Wen;
Jing Zhang;
Jing Ren;
Jing Wang;
Hongqian Guo;
Weijun Qin

Publication type:

Article

Out with the Old, in with the New: Can We Bridge the Gap Between Clinical Trial Results Based on Bone Scans and the Era of Modern Prostate Cancer Imaging?

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1748, doi. 10.2967/jnumed.123.266025

By:

Eifer, Michal;
Alipour, Ramin;
Hofman, S.;
Kumar, Aravind S. Ravi

Publication type:

Article

Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1744, doi. 10.2967/jnumed.123.265916

By:

Hope, Thomas A.;
Benz, Matthias;
Fei Jiang;
Thompson, Daniel;
Barbato, Francesco;
Juarez, Roxana;
Pampaloni, Miguel Hernandez;
Allen-Auerbach, Martin;
Gupta, Pawan;
Fendler, Wolfgang P.;
Calais, Jeremie

Publication type:

Article

Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1737, doi. 10.2967/jnumed.122.265155

By:

Murthy, Vishnu;
Gafita, Andrei;
Thin, Pan;
Nguyen, Kathleen;
Grogan, Tristan;
Shen, John;
Drakaki, Alexandra;
Rettig, Matthew;
Czernin, Johannes;
Calais, Jeremie

Publication type:

Article

Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1730, doi. 10.2967/jnumed.123.265980

By:

Kluge, Kilian;
Haberl, David;
Einspieler, Holger;
Rasul, Sazan;
Gutschmayer, Sebastian;
Kenner, Lukas;
Kramer, Gero;
Grubmüller, Bernhard;
Shariat, Shahrokh;
Haug, Alexander;
Hacker, Marcus

Publication type:

Article

[177Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1726, doi. 10.2967/jnumed.123.266141

By:

Satapathy, Swayamjeet;
Mittal, Bhagwant Rai;
Sood, Ashwani;
Das, Chandan Krushna;
Mavuduru, Ravimohan Suryanarayan;
Goyal, Shikha;
Shukla, Jaya;
Singh, Shrawan Kumar

Publication type:

Article

Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1721, doi. 10.2967/jnumed.123.266167

By:

Sartor, Oliver;
Ledet, Elisa;
Huang, Minqui;
Schwartz, Jennifer;
Lieberman, Alex;
Lewis, Brian;
Layton, Jodi;
Barata, Pedro;
Jang, Albert;
Hawkins, Madeline;
Pocha, Olivia;
Lanka, Sree;
Harris, Kendra

Publication type:

Article

Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1712, doi. 10.2967/jnumed.123.266046

By:

Koerber, Stefan A.;
Röhrich, Manuel;
Walkenbach, Leon;
Liermann, Jakob;
Choyke, Peter L.;
Fink, Christoph;
Schroeter, Cathrin;
Spektor, Anna-Maria;
Herfarth, Klaus;
Walle, Thomas;
Calais, Jeremie;
Kauczor, Hans-Ulrich;
Jaeger, Dirk;
Debus, Juergen;
Haberkorn, Uwe;
Giesel, Frederik L.

Publication type:

Article

FAPI PET/CT Immune-Fibrosis Imaging for New Insights into Rheumatologic Disorders.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1674, doi. 10.2967/jnumed.123.266182

By:

Schmidkonz, Christian;
Atzinger, Armin;
Ramming, Andreas;
Kuwert, Torsten

Publication type:

Article

Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1706, doi. 10.2967/jnumed.123.265871

By:

Itti, Emmanuel;
Blanc-Durand, Paul;
Berriolo-Riedinger, Alina;
Kanoun, Salim;
Kraeber-Bodéré, Françoise;
Meignan, Michel;
Gat, Elodie;
Le Gouill, Steven;
Casasnovas, René-Olivier;
Bodet-Milin, Caroline

Publication type:

Article

18F-FDG PET "Metabolic Response" to Neoadjuvant Systemic Therapy for Breast Cancer: Quo Vadis?

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1697, doi. 10.2967/jnumed.123.266303

By:

Gebhart, Geraldine

Publication type:

Article

Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial).

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1690, doi. 10.2967/jnumed.123.265853

By:

Hennessy, Maeve A.;
Leal, Jeffrey P.;
Chiung-Yu Huang;
Solnes, Lilja B.;
Denbow, Rita;
Abramson, Vandana G.;
Carey, Lisa A.;
Liu, Minetta C.;
Rimawi, Mothaffar;
Specht, Jennifer;
Storniolo, Anna Maria;
Valero, Vicente;
Vaklavas, Christos;
Winer, Eric P.;
Krop, Ian E.;
Wolff, Antonio C.;
Cimino-Mathews, Ashley;
Wahl, Richard L.;
Stearns, Vered;
Connolly, Roisin M.

Publication type:

Article

Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using 18F-FET PET.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1683, doi. 10.2967/jnumed.123.265642

By:

Lohmeier, Johannes;
Radbruch, Helena;
Brenner, Winfried;
Hamm, Bernd;
Tietze, Anna;
Makowski, Marcus R.

Publication type:

Article

The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1676, doi. 10.2967/jnumed.123.265906

By:

Signore, Alberto;
Ordonez, Alvaro A.;
Arjun, Chanda;
Aulakh, Gurpreet Kaur;
Beziere, Nicolas;
Dadachova, Ekaterina;
Ebenhan, Thomas;
Granados, Ulises;
Korde, Aruna;
Jalilian, Amirreza;
Lestari, Wening;
Mukherjee, Archana;
Petrik, Milos;
Sakr, Tamer;
Cuevas, Clara L. Santos;
Welling, Mick M.;
Zeevaart, Jan Rijn;
Jain, Sanjay K.;
Wilson, David M.

Publication type:

Article

High Tumor Uptake on 18F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1699, doi. 10.2967/jnumed.123.265584

By:

De Rycke, Ophélie;
Perrier, Marine;
Ouvrard, Éric;
Mennetrey, Clément;
Lachachi, Choaib;
Bando-Delaunay, Aurélie;
Morland, David;
Goichot, Bernard;
Taieb, David;
Walter, Thomas;
Cadiot, Guillaume;
Cros, Jérôme;
Hentic, Olivia;
Ruszniewski, Philippe;
Lebtahi, Rachida;
Imperiale, Alessio;
de Mestier, Louis

Publication type:

Article

Advancing Nuclear Medicine at the Multiomics Intersection: Johannes Czernin Discusses Innovation and Translation with Kalevi Kairemo.

Published in:

Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1671, doi. 10.2967/jnumed.123.266793

By:

Kairemo, Kalevi;
Czernin, Johannes

Publication type:

Article

Works matching IS 01615505 AND DT 2023 AND VI 64 AND IP 11

HER2-Low Breast Cancer Can Be Visualized by HER2 PET.

REPLY.

Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [<sup>68</sup>Ga]Ga-FAPI-46 PET-Positive and [<sup>18</sup>F]FDG PET-Negative.

Total-Body Perfusion Imaging with [<sup>11</sup>C]-Butanol.

Total-Body Multiparametric PET Quantification of <sup>18</sup>F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery.

Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab.

Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease.

Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies.

Optimized Methods for the Production of High-Purity <sup>203</sup>Pb Using Electroplated Thallium Targets.

Second Symposium of the European Working Group on the Radiobiology of Molecular Radionuclide Therapy.

Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer.

Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer.

Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&T.

Prediction of Response to <sup>177</sup>Lu-PSMA Therapy Based on Tumor-to-Kidney Ratio on Pretherapeutic PSMA PET/CT and Posttherapeutic Tumor-Dose Evaluation in mCRPC.

A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study.

Out with the Old, in with the New: Can We Bridge the Gap Between Clinical Trial Results Based on Bone Scans and the Era of Modern Prostate Cancer Imaging?

Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers.

Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with <sup>177</sup>Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis.

Antihormonal-Treatment Status Affects <sup>68</sup>Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer.

[<sup>177</sup>Lu]Lu-PSMA-617 Versus Docetaxel in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: Final Survival Analysis of a Phase 2 Randomized, Controlled Trial.

Prediction of Resistance to <sup>177</sup>Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers.

Impact of <sup>68</sup>Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers.

FAPI PET/CT Immune-Fibrosis Imaging for New Insights into Rheumatologic Disorders.

Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.

<sup>18</sup>F-FDG PET "Metabolic Response" to Neoadjuvant Systemic Therapy for Breast Cancer: Quo Vadis?

Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial).

Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using <sup>18</sup>F-FET PET.

The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection.

High Tumor Uptake on <sup>18</sup>F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network.

Advancing Nuclear Medicine at the Multiomics Intersection: Johannes Czernin Discusses Innovation and Translation with Kalevi Kairemo.